Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2022 May 20

PMID 35594490

Authors

Diane M Harper

Affiliations

Soon will be listed here.

Citing Articles

Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study.

Liu Y, Chen Y, Xiong J, Zhu P, An Y, Li S Infect Agent Cancer. 2023; 18(1):77.

PMID: 38031140 PMC: 10687787. DOI: 10.1186/s13027-023-00555-2.

Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.

Gibson-Helm M, Slater T, MacDonald E, Stevenson K, Adcock A, Geller S PLoS One. 2023; 18(3):e0280643.

PMID: 36952546 PMC: 10035917. DOI: 10.1371/journal.pone.0280643.

Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.

Cooley J, Maguire F, Morris C, Parikh-Patel A, Abrahao R, Chen H Cancer Epidemiol Biomarkers Prev. 2023; 32(1):91-97.

PMID: 36620897 PMC: 9833840. DOI: 10.1158/1055-9965.EPI-22-0793.

References

PAPANICOLAOU G, TRAUT H . The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. Arch Pathol Lab Med. 1997; 121(3):211-24. View

Egemen D, Cheung L, Chen X, Demarco M, Perkins R, Kinney W . Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis. 2020; 24(2):132-143. PMC: 7147417. DOI: 10.1097/LGT.0000000000000529. View

Kremer W, Dick S, Heideman D, Steenbergen R, Bleeker M, Verhoeve H . Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of DNA Methylation (CONCERVE Study). J Clin Oncol. 2022; 40(26):3037-3046. PMC: 9462536. DOI: 10.1200/JCO.21.02433. View

Saraiya M, Steben M, Watson M, Markowitz L . Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev Med. 2013; 57(5):426-33. PMC: 4515308. DOI: 10.1016/j.ypmed.2013.01.020. View

Bonde J, Pedersen H, Quint W, Xu L, Arbyn M, Ejegod D . Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework. J Clin Microbiol. 2019; 58(2). PMC: 6989063. DOI: 10.1128/JCM.01518-19. View

Polman N, Snijders P, Kenter G, Berkhof J, Meijer C . HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme. Prev Med. 2018; 119:108-117. DOI: 10.1016/j.ypmed.2018.12.021. View

Lorincz A . Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention. Acta Cytol. 2016; 60(6):501-512. DOI: 10.1159/000450595. View

Solomon D, Schiffman M, Tarone R . Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001; 93(4):293-9. DOI: 10.1093/jnci/93.4.293. View

Inturrisi F, Aitken C, Melchers W, van den Brule A, Molijn A, Hinrichs J . Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study. Lancet Reg Health Eur. 2021; 11:100235. PMC: 8642706. DOI: 10.1016/j.lanepe.2021.100235. View

10.

Ebisch R, van der Horst J, Hermsen M, Rijstenberg L, Vedder J, Bulten J . Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. Mod Pathol. 2017; 30(7):1021-1031. DOI: 10.1038/modpathol.2017.16. View

11.

Gibb R, Martens M . The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 2011; 4(Suppl 1):S2-S11. PMC: 3101960. View

12.

Perkins R, Adcock R, Benard V, Cuzick J, Waxman A, Howe J . Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations. Prev Med. 2021; 153:106770. PMC: 8595756. DOI: 10.1016/j.ypmed.2021.106770. View

13.

De Strooper L, Meijer C, Berkhof J, Hesselink A, Snijders P, Steenbergen R . Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prev Res (Phila). 2014; 7(12):1251-7. DOI: 10.1158/1940-6207.CAPR-14-0237. View

14.

Vink F, Meijer C, Clifford G, Poljak M, Ostrbenk A, Petry K . FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study. Int J Cancer. 2019; 147(4):1215-1221. PMC: 7383900. DOI: 10.1002/ijc.32614. View

15.

Maver P, Poljak M . Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2019; 26(5):579-583. DOI: 10.1016/j.cmi.2019.09.006. View

16.

Snoek B, van Splunter A, Bleeker M, Ruiten M, Heideman D, Rurup W . Cervical cancer detection by DNA methylation analysis in urine. Sci Rep. 2019; 9(1):3088. PMC: 6395822. DOI: 10.1038/s41598-019-39275-2. View

17.

Serrano B, Ibanez R, Robles C, Peremiquel-Trillas P, de Sanjose S, Bruni L . Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med. 2021; 154:106900. DOI: 10.1016/j.ypmed.2021.106900. View

18.

Sankaranarayanan R, Prabhu P, Pawlita M, Gheit T, Bhatla N, Muwonge R . Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study. Lancet Oncol. 2015; 17(1):67-77. PMC: 5357737. DOI: 10.1016/S1470-2045(15)00414-3. View

19.

Hwang S, Shin H, Lee D, Sung N, Lee B, Lee D . A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening. Sci Rep. 2018; 8(1):9015. PMC: 5998027. DOI: 10.1038/s41598-018-27390-5. View

20.

Mariz F, Gray P, Bender N, Eriksson T, Kann H, Apter D . Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials. Lancet Infect Dis. 2021; 21(10):1458-1468. DOI: 10.1016/S1473-3099(20)30873-2. View